Clinical trial data validate the C-peptide estimate model in type 1 diabetes
dc.contributor.author | Wentworth, John M. | |
dc.contributor.author | Bediaga, Naiara G. | |
dc.contributor.author | Gitelman, Stephen E. | |
dc.contributor.author | Evans-Molina, Carmela | |
dc.contributor.author | Gottlieb, Peter A. | |
dc.contributor.author | Colman, Peter G. | |
dc.contributor.author | Haller, Michael J. | |
dc.contributor.author | Harrison, Leonard C. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2022-11-04T15:05:20Z | |
dc.date.available | 2022-11-04T15:05:20Z | |
dc.date.issued | 2020-04 | |
dc.eprint.version | Author's manuscript | en_US |
dc.identifier.citation | Wentworth JM, Bediaga NG, Gitelman SE, et al. Clinical trial data validate the C-peptide estimate model in type 1 diabetes. Diabetologia. 2020;63(4):885-886. doi:10.1007/s00125-020-05088-6 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/30472 | |
dc.language.iso | en_US | en_US |
dc.publisher | SpringerLink | en_US |
dc.relation.isversionof | 10.1007/s00125-020-05088-6 | en_US |
dc.relation.journal | Diabetologia | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Antilymphocyte serum | en_US |
dc.subject | C-Peptide | en_US |
dc.subject | Type 1 Diabetes Mellitus | en_US |
dc.title | Clinical trial data validate the C-peptide estimate model in type 1 diabetes | en_US |
dc.type | Article | en_US |